CEMI:CA:TSX-CIBC Emerging Markets Equity Index ETF (CAD)

ETF | Others |

Last Closing

CAD 17.43

Change

+0.08 (+0.46)%

Market Cap

CAD 0.06B

Volume

3.80K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.02 (+0.04%)

CAD 4.87B
PHYS-U:CA Sprott Physical Gold Trust

-0.28 (-1.56%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.94 (+1.48%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

+0.53 (+1.31%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
XEQT:CA iShares Core Equity Portfolio

+0.29 (+0.98%)

CAD 3.29B
PSLV-U:CA Sprott Physical Silver Trust

-0.12 (-1.33%)

CAD 3.29B
IGAF:CA IA Clarington Loomis Global Al..

N/A

CAD 3.23B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.14 (+0.65%)

CAD 2.78B

ETFs Containing CEMI:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.38% 53% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.38% 53% F 47% F
Trailing 12 Months  
Capital Gain 4.75% 48% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.75% 47% F 48% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -1.73% 30% F 32% F
Dividend Return -1.73% 29% F 24% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.33% 56% F 78% C+
Risk Adjusted Return -23.58% 30% F 22% F
Market Capitalization 0.06B 55% F 29% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.